Compare · DASH vs GDRX
DASH vs GDRX
Side-by-side comparison of DoorDash Inc. (DASH) and GoodRx Holdings Inc. (GDRX): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both DASH and GDRX operate in EDP Services (Technology), so they compete in similar markets.
- DASH is the larger of the two at $35.57B, about 33.4x GDRX ($1.06B).
- DASH has been more active in the news (8 items in the past 4 weeks vs 4 for GDRX).
- Both have 25 recent analyst ratings on file.
- Company
- DoorDash Inc.
- GoodRx Holdings Inc.
- Price
- -
- -
- Market cap
- $35.57B
- $1.06B
- 1M return
- -
- +14.44%
- 1Y return
- -
- -34.24%
- Industry
- EDP Services
- EDP Services
- Exchange
- NYSE
- NASDAQ
- IPO
- 2020
- News (4w)
- 8
- 4
- Recent ratings
- 25
- 25
DoorDash Inc.
DoorDash, Inc. operates a logistics platform that connects merchants, consumers, and dashers in the United States and internationally. It operates DoorDash marketplace, which provides an array of services that enable merchants to solve mission-critical challenges, such as customer acquisition, delivery, insights and analytics, merchandising, payment processing, and customer support; and offers DoorDash Drive, a white-label logistics service; DoorDash Storefront that enables merchants to offer consumers on-demand access to e-commerce. The company was formerly known as Palo Alto Delivery Inc. and changed its name to DoorDash, Inc. in 2015. DoorDash, Inc. was founded in 2013 and is headquartered in San Francisco, California.
GoodRx Holdings Inc.
GoodRx Holdings, Inc., through its subsidiaries, provides information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices through GoodRx codes that are used to save money on prescriptions across the United States. It also offers other healthcare products and services, including telehealth services. The company serves pharmacy benefit managers that manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies. GoodRx Holdings, Inc. was incorporated in 2015 and is based in Santa Monica, California.
Latest DASH
- Wedbush resumed coverage on DoorDash with a new price target
- DoorDash Integrates Directly with Shopify to Connect Brick-and-Mortar Retailers with On-Demand Delivery
- Hungry Howie's and DoorDash Partner to Create a More Seamless Digital Ordering and Loyalty Experience
- CHIEF FINANCIAL OFFICER Inukonda Ravi exercised 4,068 shares at a strike of $7.66 and sold $3,590,633 worth of shares (19,095 units at $188.04) as part of a pre-agreed trading plan, decreasing direct ownership by 6% to 252,443 units (SEC Form 4)
- Director Tang Stanley acquired 23,125 shares as part of a pre-agreed trading plan and sold $4,421,342 worth of shares (23,125 units at $191.19) as part of a pre-agreed trading plan (SEC Form 4)
- Director Fang Andy acquired 5,000 shares as part of a pre-agreed trading plan and sold $925,096 worth of shares (5,000 units at $185.02) as part of a pre-agreed trading plan (SEC Form 4)
- DoorDash to Announce Second Quarter 2026 Results on August 5, 2026
- Director Brown Shona L sold $103,049 worth of shares (582 units at $177.06) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 31,156 units (SEC Form 4)
- SEC Form 144 filed by DoorDash Inc.
- Director Fang Andy acquired 5,000 shares as part of a pre-agreed trading plan and sold $900,000 worth of shares (5,000 units at $180.00) as part of a pre-agreed trading plan (SEC Form 4)
Latest GDRX
- Officer Mcginnis Christopher A converted options into 36,988 shares and covered exercise/tax liability with 16,294 shares, increasing direct ownership by 12% to 198,310 units (SEC Form 4)
- Officer Barnes Wendy Lynn covered exercise/tax liability with 120,456 shares and converted options into 277,288 shares, increasing direct ownership by 27% to 741,657 units (SEC Form 4)
- Chief Accounting Officer Chan Thomas (Tc) converted options into 5,792 shares and covered exercise/tax liability with 2,947 shares, increasing direct ownership by 50% to 8,580 units (SEC Form 4)
- GoodRx Announces Date for Second Quarter 2026 Earnings Release and Conference Call
- GoodRx Holdings Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
- Director Rey-Giraud Agnes was granted 73,434 shares, increasing direct ownership by 21% to 426,286 units (SEC Form 4)
- Director Kennedy Kelly J. was granted 73,434 shares, increasing direct ownership by 55% to 207,645 units (SEC Form 4)
- Director Hirsch Douglas Joseph was granted 73,434 shares, increasing direct ownership by 30% to 320,936 units (SEC Form 4)
- Director Bruehlman Ronald E was granted 73,434 shares, increasing direct ownership by 55% to 207,352 units (SEC Form 4)
- Director Bezdek Trevor was granted 73,434 shares, increasing direct ownership by 27% to 343,810 units (SEC Form 4)